Relative Value Partners Group, LLC Abbott Laboratories Transaction History

Relative Value Partners Group, LLC

$751 Million
Q2 2024

A detailed history of Relative Value Partners Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 7,330 shares of ABT stock, worth $837,305. This represents 0.1% of its overall portfolio holdings.

Number of Shares

7,330

Previous 9,331 21.44%

Holding current value

$837,305

Previous $1.06 Million 28.21%

% of portfolio

0.1%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$100.73 - $112.44 $201,560 - $224,992	-2,001 Reduced 21.44%	7,330 $761,000
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $438 - $483	4 Added 0.04%	9,331 $1.06 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $4,960 - $6,072	55 Added 0.59%	9,327 $1.03 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $128,869 - $154,622	1,349 Added 17.03%	9,272 $897,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $148,146 - $165,066	-1,470 Reduced 15.65%	7,923 $863,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $60,053 - $70,686	-620 Reduced 6.19%	9,393 $951,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $362,653 - $425,448	3,815 Added 61.55%	10,013 $1.1 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $599,718 - $694,361	6,198 New	6,198 $600,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $1.28 Million - $1.55 Million	-12,549 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $784,229 - $956,317	6,878 Added 121.28%	12,549 $1.49 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $182,487 - $214,814	-1,725 Reduced 23.32%	5,671 $657,000
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $25,903 - $30,518	-238 Reduced 3.12%	7,396 $886,000
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $156,135 - $170,142	1,487 Added 24.19%	7,634 $836,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $209,504 - $306,353	3,335 Added 118.6%	6,147 $485,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $25,672 - $28,579	327 Added 13.16%	2,812 $244,000
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $71,495 - $83,385	-981 Reduced 28.3%	2,485 $209,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $229,518 - $277,487	3,466 New	3,466 $277,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Account

Relative Value Partners Group, LLC Abbott Laboratories Transaction History